SaratogaRIM Lge Cap Quality Focus ESG (S:0P0001RBGN)
12.63
-0.40
(-3.08%)
USD |
Oct 31 2024
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
| Maximum Management Fee | Annualized Total Returns Since Inception (Daily) | Alpha (vs Category) (3Y) | Forecasted Dividend Yield |
|---|---|---|---|
| -- | -- | -- | -- |
| Total Market Value (Net) | Beta (vs Category) (3Y) | Max Drawdown (Since Inception) | Fwd Dividend Yield (Long) |
| Upgrade | Upgrade | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| Standard & Poor's | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Adam Sato | 3.42 yrs |
| Andrew Early | 3.42 yrs |
| Joseph Pollard | 3.42 yrs |
| Kevin Tanner | 3.42 yrs |
| Marc Crosby | 3.42 yrs |
| Mathew Spencer | 3.42 yrs |
| Matt Keating | 3.42 yrs |
| Matthew Casas | 3.42 yrs |
| Philip Spencer | 3.42 yrs |
| Robert Meng | 3.42 yrs |
Annual Total Returns Versus Peers
As of November 14, 2024.
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | -- | -- | -- |
| Stock | -- | -- | -- |
| Bond | -- | -- | -- |
| Convertible | -- | -- | -- |
| Preferred | -- | -- | -- |
| Other | -- | -- | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Oracle Corp | 7.21% | 187.10 | -1.33% |
| Microsoft Corp | 6.90% | 426.88 | 0.40% |
| Alphabet Inc Class A | 6.82% | 175.68 | -1.79% |
| Unilever PLC ADR | 6.77% | 57.39 | 0.02% |
| Medtronic PLC | 6.72% | 85.98 | -2.26% |
| The Walt Disney Co | 6.60% | 109.13 | 6.24% |
| Roche Holding AG ADR | 5.86% | 36.14 | -2.38% |
| Accenture PLC Class A | 5.50% | 362.05 | -2.21% |
| Johnson & Johnson | 5.38% | 151.85 | -0.91% |
| Berkshire Hathaway Inc Class B | 4.24% | 467.72 | -0.08% |
Fees & Availability
| Fees | |
| Negotiable Fee | No |
| Administrative Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Trustee Fee | -- |
| Purchase Details | |
| Open to New Investors | No |
| Open to Existing Investors | No |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| Standard & Poor's | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Adam Sato | 3.42 yrs |
| Andrew Early | 3.42 yrs |
| Joseph Pollard | 3.42 yrs |
| Kevin Tanner | 3.42 yrs |
| Marc Crosby | 3.42 yrs |
| Mathew Spencer | 3.42 yrs |
| Matt Keating | 3.42 yrs |
| Matthew Casas | 3.42 yrs |
| Philip Spencer | 3.42 yrs |
| Robert Meng | 3.42 yrs |
Fundamentals
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Forecasted Dividend Yield | -- |
| Forecasted PE Ratio | -- |
| Forecasted Price to Sales Ratio | -- |
| Forecasted Price to Book Ratio | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |